162 related articles for article (PubMed ID: 27756250)
1. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W
BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250
[TBL] [Abstract][Full Text] [Related]
2. FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2.
Liu LL; Lu SX; Li M; Li LZ; Fu J; Hu W; Yang YZ; Luo RZ; Zhang CZ; Yun JP
Oncotarget; 2014 Jul; 5(13):5113-24. PubMed ID: 24970808
[TBL] [Abstract][Full Text] [Related]
3. microRNA-874 suppresses tumor proliferation and metastasis in hepatocellular carcinoma by targeting the DOR/EGFR/ERK pathway.
Zhang Y; Wei Y; Li X; Liang X; Wang L; Song J; Zhang X; Zhang C; Niu J; Zhang P; Ren Z; Tang B
Cell Death Dis; 2018 Jan; 9(2):130. PubMed ID: 29374140
[TBL] [Abstract][Full Text] [Related]
4. CTNNA3 is a tumor suppressor in hepatocellular carcinomas and is inhibited by miR-425.
He B; Li T; Guan L; Liu FE; Chen XM; Zhao J; Lin S; Liu ZZ; Zhang HQ
Oncotarget; 2016 Feb; 7(7):8078-89. PubMed ID: 26882563
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-23a downregulates the expression of interferon regulatory factor-1 in hepatocellular carcinoma cells.
Yan Y; Liang Z; Du Q; Yang M; Geller DA
Oncol Rep; 2016 Aug; 36(2):633-40. PubMed ID: 27279136
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Tumorigenesis in Hepatocellular Carcinoma via the AKT3 Pathway in Cell Lines.
Xing M; Xie X; Liu Z; Du X
Comput Math Methods Med; 2021; 2021():3267536. PubMed ID: 34745324
[TBL] [Abstract][Full Text] [Related]
7. A feedback inhibition between miRNA-127 and TGFβ/c-Jun cascade in HCC cell migration via MMP13.
Yang Z; Zhang Y; Wang L
PLoS One; 2013; 8(6):e65256. PubMed ID: 23762330
[TBL] [Abstract][Full Text] [Related]
8. Replication Protein A 3 Is Associated with Hepatocellular Carcinoma Tumorigenesis and Poor Patient Survival.
Xiao W; Zheng J; Zhou B; Pan L
Dig Dis; 2018; 36(1):26-32. PubMed ID: 28683444
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between macrophage-derived PGE
Zhang J; Zhang H; Ding X; Hu J; Li Y; Zhang J; Wang H; Qi S; Xie A; Shi J; Xiang M; Bin Y; Wang G; Wang L; Wang Z
Theranostics; 2022; 12(8):3776-3793. PubMed ID: 35664070
[No Abstract] [Full Text] [Related]
10. miR-10b-5p promotes tumor growth by regulating cell metabolism in liver cancer via targeting SLC38A2.
Xia M; Chen J; Hu Y; Qu B; Bu Q; Shen H
Cancer Biol Ther; 2024 Dec; 25(1):2315651. PubMed ID: 38390840
[TBL] [Abstract][Full Text] [Related]
11. Effect of miR-4270 Suppression on Migration in Hepatocellular Carcinoma Cell Line (HepG2).
Akrami H; Gholami H; Fattahi MR; Zeraatiannejad M
Iran Biomed J; 2023 Jul; 27(4):167-72. PubMed ID: 37430248
[TBL] [Abstract][Full Text] [Related]
12. Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer.
Luna JM; Barajas JM; Teng KY; Sun HL; Moore MJ; Rice CM; Darnell RB; Ghoshal K
Mol Cell; 2017 Aug; 67(3):400-410.e7. PubMed ID: 28735896
[TBL] [Abstract][Full Text] [Related]
13. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis.
Datta J; Kutay H; Nasser MW; Nuovo GJ; Wang B; Majumder S; Liu CG; Volinia S; Croce CM; Schmittgen TD; Ghoshal K; Jacob ST
Cancer Res; 2008 Jul; 68(13):5049-58. PubMed ID: 18593903
[TBL] [Abstract][Full Text] [Related]
14. MiR-3150b inhibits hepatocellular carcinoma cell proliferation, migration and invasion by targeting GOLPH3.
Zhang Y; Wang J; Su H
J Investig Med; 2020 Mar; 68(3):770-775. PubMed ID: 31806673
[TBL] [Abstract][Full Text] [Related]
15. Human MiR-544a Modulates SELK Expression in Hepatocarcinoma Cell Lines.
Potenza N; Castiello F; Panella M; Colonna G; Ciliberto G; Russo A; Costantini S
PLoS One; 2016; 11(6):e0156908. PubMed ID: 27275761
[TBL] [Abstract][Full Text] [Related]
16. Enhanced glucose metabolism mediated by CD147 contributes to immunosuppression in hepatocellular carcinoma.
Li X; Zhang Y; Ma W; Fu Q; Liu J; Yin G; Chen P; Dai D; Chen W; Qi L; Yu X; Xu W
Cancer Immunol Immunother; 2020 Apr; 69(4):535-548. PubMed ID: 31965268
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinoma.
Yoo BK; Emdad L; Gredler R; Fuller C; Dumur CI; Jones KH; Jackson-Cook C; Su ZZ; Chen D; Saxena UH; Hansen U; Fisher PB; Sarkar D
Proc Natl Acad Sci U S A; 2010 May; 107(18):8357-62. PubMed ID: 20404171
[TBL] [Abstract][Full Text] [Related]
18. A Comprehensive Analysis of Argonaute-CLIP Data Identifies Novel, Conserved and Species-Specific Targets of miR-21 in Human Liver and Hepatocellular Carcinoma.
Koenig AB; Barajas JM; Guerrero MJ; Ghoshal K
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29538313
[TBL] [Abstract][Full Text] [Related]
19. miR-4270 suppresses hepatocellular carcinoma progression by inhibiting DNMT3A-mediated methylation of HGFAC promoter.
Zou Q; Cao S
PeerJ; 2023; 11():e16566. PubMed ID: 38077422
[TBL] [Abstract][Full Text] [Related]
20. Rictor mediates p53 deactivation to facilitate the malignant transformation of hepatocytes and promote hepatocarcinogenesis.
Wang C; Kang H; Yi Y; Ding Y; Wang F; Luo J; Ye M; Hong Y; Xia C; Yan J; Liu L; Liu J; Zhong Z; Zhang Z; Zhao Q; Chang Y
J Transl Med; 2023 Dec; 21(1):919. PubMed ID: 38110956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
